Austral Gold Releases Updated Corporate Presentation. Sydney, Australia--(Newsfile Corp. - 10, 2025) - Austral Gold Limited (ASX: AGD) (TSXV: AGLD) (OTCQB: AGLDF) (Austral or the Company), an ...

Akari Therapeutics ( ($AKTX) ) just unveiled an announcement. On December 8, 2025, Akari Therapeutics, Plc prepared an investor presentation for ...

HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced that new clinical data from ...

Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage position Plinabulin as a late-stage candidate showing survival improvement ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint ...

Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage position Plinabulin ...

An announcement from Perspective Therapeutics ( ($CATX) ) is now available. On December 1, 2025, Perspective Therapeutics updated its corporate ...

Data demonstrate superior efficacy compared to ruxolitinib, an approved type I JAK2 inhibitor, including reductions in mutant ...

Accelerating an Anthracycline-Free Future: A New Drug in Clinical Testing Offers Patients Hope for Safer, More Effective Breast Cancer Therapy Combinations Date: Thursday, December 11, 2025 Time: 5 p.

Benjamin Ball Associates, a London-based executive coaching and presentation training firm, has announced the extension of its services to professionals and organisations in several new districts ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company”), a clinical-stage pharmaceutical company developing targeted ...

Netflix has admitted it did not attribute any value to Warner Bros.’ video game business in its $82.7 billion acquisition deal, sparking concern for the future of everything from Mortal Kombat to ...